News
12-11-2024, 10:06 AM
Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing salpingo-oophorectomy (RRSO) had lower rates of recurrence, secondary breast and/or ovarian malignancies, and death than those who did not undergo these surgeries, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
More... (https://www.news-medical.net/news/20241211/Risk-reducing-surgeries-provide-benefits-for-young-BRCA-mutation-carriers.aspx)
More... (https://www.news-medical.net/news/20241211/Risk-reducing-surgeries-provide-benefits-for-young-BRCA-mutation-carriers.aspx)